Ambareesh Baliga of Edelweiss told CNBC-TV18, "Ranbaxy Laboratories has fallen from close to Rs 450 to about Rs 320-330 and from there a bounce back is quite natural. I don’t know whether it will take it to Rs 390, but at least the way the momentum is there, Rs 365-370 is very much possible in it."
Ranbaxy Laboratories today closed at Rs 350, up 5.84 percent from previous close on the Bombay Stock Exchange. The share touched its 52-week high Rs 559.80 and 52-week low Rs 253.95 on 08 November, 2012 and 02 August, 2013, respectively. Also Read: Daiichi to cooperate with USFDA to resolve Ranbaxy concernsDiscover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
